Jeet Mukherjee
Stock Analyst at BTIG
(4.67)
# 144
Out of 5,150 analysts
32
Total ratings
71.88%
Success rate
25.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jeet Mukherjee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AARD Aardvark Therapeutics | Maintains: Buy | $26 → $9 | $5.64 | +59.57% | 3 | Mar 2, 2026 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $138 → $134 | $86.11 | +55.61% | 6 | Feb 26, 2026 | |
| PVLA Palvella Therapeutics | Maintains: Buy | $192 → $215 | $135.49 | +58.68% | 5 | Feb 25, 2026 | |
| MNPR Monopar Therapeutics | Reiterates: Buy | $104 | $55.49 | +87.42% | 6 | Feb 23, 2026 | |
| NRIX Nurix Therapeutics | Reiterates: Buy | $30 | $16.26 | +84.50% | 5 | Jan 29, 2026 | |
| CATX Perspective Therapeutics | Reiterates: Buy | $14 | $5.27 | +165.65% | 3 | Jan 13, 2026 | |
| BCAX Bicara Therapeutics | Initiates: Buy | $28 | $18.54 | +51.02% | 1 | Jan 8, 2026 | |
| FHTX Foghorn Therapeutics | Initiates: Buy | $11 | $5.67 | +94.00% | 1 | Dec 18, 2025 | |
| ARVN Arvinas | Maintains: Buy | $10 → $14 | $13.76 | +1.74% | 2 | Oct 30, 2025 |
Aardvark Therapeutics
Mar 2, 2026
Maintains: Buy
Price Target: $26 → $9
Current: $5.64
Upside: +59.57%
Kymera Therapeutics
Feb 26, 2026
Maintains: Buy
Price Target: $138 → $134
Current: $86.11
Upside: +55.61%
Palvella Therapeutics
Feb 25, 2026
Maintains: Buy
Price Target: $192 → $215
Current: $135.49
Upside: +58.68%
Monopar Therapeutics
Feb 23, 2026
Reiterates: Buy
Price Target: $104
Current: $55.49
Upside: +87.42%
Nurix Therapeutics
Jan 29, 2026
Reiterates: Buy
Price Target: $30
Current: $16.26
Upside: +84.50%
Perspective Therapeutics
Jan 13, 2026
Reiterates: Buy
Price Target: $14
Current: $5.27
Upside: +165.65%
Bicara Therapeutics
Jan 8, 2026
Initiates: Buy
Price Target: $28
Current: $18.54
Upside: +51.02%
Foghorn Therapeutics
Dec 18, 2025
Initiates: Buy
Price Target: $11
Current: $5.67
Upside: +94.00%
Arvinas
Oct 30, 2025
Maintains: Buy
Price Target: $10 → $14
Current: $13.76
Upside: +1.74%